BBC vs. HEAL
BBC (Virtus LifeSci Biotech Clinical Trials ETF) and HEAL (Global X HealthTech ETF) are both Health & Biotech Equities funds - BBC tracks the LifeSci Biotechnology Clinical Trials Index while HEAL tracks the Global X HealthTech Index. Both are passively managed. Over the past 5 years, BBC returned -2.05%/yr vs -14.38%/yr for HEAL. A 0.64 correlation means they provide meaningful diversification when combined. BBC charges 0.79%/yr vs 0.50%/yr for HEAL.
Performance
BBC vs. HEAL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BBC achieves a 8.17% return, which is significantly higher than HEAL's -14.58% return.
BBC
- 1D
- -4.90%
- 1M
- -4.81%
- YTD
- 8.17%
- 6M
- 20.12%
- 1Y
- 123.11%
- 3Y*
- 19.82%
- 5Y*
- -2.05%
- 10Y*
- 7.60%
HEAL
- 1D
- -2.31%
- 1M
- -1.49%
- YTD
- -14.58%
- 6M
- -19.25%
- 1Y
- -20.75%
- 3Y*
- -10.11%
- 5Y*
- -14.38%
- 10Y*
- —
BBC vs. HEAL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 8.17% | 63.77% | -1.11% | -1.80% | -35.13% | -22.31% | 24.21% |
HEAL Global X HealthTech ETF | -14.58% | -0.62% | -2.87% | -12.61% | -29.99% | -14.21% | 23.87% |
Correlation
The correlation between BBC and HEAL is 0.50, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.50 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.55 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.63 |
Correlation (All Time) Calculated using the full available price history since Jul 31, 2020 | 0.64 |
The correlation between BBC and HEAL shifts across timeframes, from 0.50 (1 year) to 0.64 (all time), reflecting how their relationship changes across market environments.
BBC vs. HEAL - Sectors Allocation Comparison
Sectors
BBC
HEAL
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
Utilities
-
-
Healthcare
BBC
HEAL
Basic Materials
BBC
-
HEAL
-
Communication Services
BBC
-
HEAL
-
Consumer Cyclical
BBC
-
HEAL
-
Consumer Defensive
BBC
-
HEAL
-
Energy
BBC
-
HEAL
-
Financial Services
BBC
-
HEAL
-
Industrials
BBC
-
HEAL
-
Real Estate
BBC
-
HEAL
-
Technology
BBC
-
HEAL
Utilities
BBC
-
HEAL
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBC vs. HEAL — Risk / Return Rank
BBC
HEAL
BBC vs. HEAL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and Global X HealthTech ETF (HEAL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BBC | HEAL | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 3.49 | -0.95 | +4.44 |
Sortino ratioReturn per unit of downside risk | 4.11 | -1.30 | +5.42 |
Omega ratioGain probability vs. loss probability | 1.48 | 0.86 | +0.62 |
Calmar ratioReturn relative to maximum drawdown | 8.82 | -0.66 | +9.48 |
Martin ratioReturn relative to average drawdown | 28.55 | -1.34 | +29.90 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BBC | HEAL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.49 | -0.95 | +4.44 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.05 | -0.55 | +0.50 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.20 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.12 | -0.39 | +0.50 |
Drawdowns
BBC vs. HEAL - Drawdown Comparison
The maximum BBC drawdown since its inception was -76.85%, which is greater than HEAL's maximum drawdown of -65.76%. Use the drawdown chart below to compare losses from any high point for BBC and HEAL.
Loading charts...
Drawdown Indicators
| BBC | HEAL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.85% | -65.76% | -11.09% |
Max Drawdown (1Y)Largest decline over 1 year | -15.10% | -30.71% | +15.61% |
Max Drawdown (3Y)Largest decline over 3 years | -54.45% | -35.78% | -18.67% |
Max Drawdown (5Y)Largest decline over 5 years | -72.44% | -60.36% | -12.08% |
Max Drawdown (10Y)Largest decline over 10 years | -76.85% | — | — |
Current DrawdownCurrent decline from peak | -30.57% | -63.12% | +32.55% |
Average DrawdownAverage peak-to-trough decline | -37.14% | -43.01% | +5.87% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.66% | 15.04% | -10.38% |
Volatility
BBC vs. HEAL - Volatility Comparison
Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a higher volatility of 11.21% compared to Global X HealthTech ETF (HEAL) at 5.09%. This indicates that BBC's price experiences larger fluctuations and is considered to be riskier than HEAL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BBC | HEAL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.21% | 5.09% | +6.12% |
Volatility (6M)Calculated over the trailing 6-month period | 26.65% | 15.71% | +10.94% |
Volatility (1Y)Calculated over the trailing 1-year period | 35.74% | 21.87% | +13.87% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.31% | 26.36% | +12.95% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 37.75% | 26.19% | +11.56% |
BBC vs. HEAL - Expense Ratio Comparison
BBC has a 0.79% expense ratio, which is higher than HEAL's 0.50% expense ratio.
Dividends
BBC vs. HEAL - Dividend Comparison
BBC's dividend yield for the trailing twelve months is around 1.57%, more than HEAL's 0.39% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.57% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
HEAL Global X HealthTech ETF | 0.39% | 0.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
BBC and HEAL have a correlation of 0.50, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBC has higher volatility (11.21%) compared to HEAL (5.09%). In terms of maximum drawdown, BBC dropped -76.85% vs HEAL's -65.76%.
On 5-year performance, BBC leads with -2.05% vs -14.38% for HEAL. On fees, HEAL is cheaper at 0.50% per year. On volatility, HEAL has been the lower-risk option at 5.09%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, BBC has performed better with a -2.05% return vs -14.38%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
HEAL is cheaper with a 0.50% expense ratio, compared with 0.79% for BBC.
BBC has the higher dividend yield at 1.57%, compared with 0.39% for HEAL.
BBC tracks LifeSci Biotechnology Clinical Trials Index, while HEAL tracks Global X HealthTech Index. They also come from different issuers: Virtus Investment Partners and Global X. Their fees differ too: 0.79% for BBC and 0.50% for HEAL.
BBC currently has the higher Sharpe Ratio (3.49 vs -0.95), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BBC and HEAL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer